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As years go, 2000 was an eventful one. It was, of course, 
the  beginning  of  a  new  millennium  (I  know,  strictly 
speaking  that  should  have  been  2001,  but  no  one 
seriously considered doing it that way). The dreaded Y2K 
bug  that  was  supposed  to  shut  down  half  the  world’s 
computers  proved  to  be  nothing  but  a  bonanza  for 
computer consultants. George W Bush was about to be 
elected President of the United States, thereby proving 
that in my country, an ordinary bloke can grow up to be 
president (provided that their father had been president, 
they came from one of the richest and most powerful 
families  in  the  land,  and  had  been  handed  virtually 
everything  they  ever  got  on  a  silver  plate).  The  most 
popular  songs  included  ‘It’s  gonna  be  me’  by  a  group 
called ‘N Sync and a rap song called ‘The real Slim Shady’ 
by Eminem. The most popular baby names for boys were 
Jacob,  Michael,  and  Joshua,  which  might  make  you 
wonder  if  the  whole  country  had  been  converted  to 
Judaism, except that the most popular girls’ names were 
Emily, Madison, and Ashley, which suggested that if it 
had, it had been converted to Jewish WASPs. The most-
watched television show in the US was a program called 
‘Survivor’. It was the first example of new concept called 
reality TV - a genre that was going to represent the nadir 
of  the  medium  for  the  entire  decade  to  come.  In  the 
movie  theatres,  the  most  popular  films  that  year  were 
‘Spider-Man’, ‘The Lord of the Rings: The Two Towers’, 
‘Star Wars: Episode II - Attack of the Clones’, and ‘Harry 
Potter and the Chamber of Secrets’ - fantasy adventures, 
every one. As the summer of 2000 approached, no one 
realized that, whereas they were immersing themselves in 
fake reality on television and fake unreality at the cinema, 
their real world was about to change forever.
On 9 June 2000, the first edition of  Genome Biology 
appeared, both online and in print. It included a column 
by yours truly called ‘The grail problem’ [1]. The second 
issue, on 28 July, contained a second opinion column by 
the same author, this one entitled ‘Dog eat dogma’ [2]; it 
discussed  how  genomics  was  changing  the  Central 
Dogma of Biology from ‘DNA makes RNA makes protein’ 
to ‘Sequence determines structure determines function.’ 
You  might  have  thought  that  this  one-to-one  mapping 
would have frightened most readers off, but that doesn’t 
seem to have happened: almost 120 issues later, both the 
journal and this column are about to celebrate their 10th 
anniversary.
Genome  Biology  was  the  brainchild  of  many  people, 
and I don’t know who all of them were. My own dealings 
at  that  time  were  primarily  with  Miranda  Robertson, 
Theo Bloom, and Vitek Tracz. Vitek was the founder of 
the  open  access  publisher  BioMed  Central,  and  in  the 
year 2000, open access publishing was regarded by many 
as a fool’s dream and by many others as a threat to their 
way of life. Vitek, Miranda, and Theo were convinced not 
only that it was a viable business model, but that it was 
the wave of the future.
And  if  open  access  publishing  was  considered  either 
heretical  or  ridiculous,  the  idea  of  a  primarily  online 
scientific  journal  was  considered  suicidal.  Yet  Genome 
Biology was conceived from the beginning as primarily an 
online  publication;  the  print  edition  that  went  out  to 
subscribers  for  the  first  few  years  was  an  afterthought 
and, frankly, looked like one.
Content  was  another  potential  problem.  In  January 
2000,  there  were  still  a  relatively  small  number  of 
complete genome sequences, and nearly all of them were 
of  prokaryotes.  The  founding  editors  and  publisher  of 
Genome Biology were betting on a revolution that really 
hadn’t started yet in the minds of many people.
In retrospect, however, the timing couldn’t have been 
better, because something else happened in June of 2000 
besides  the  launch  of  this  journal.  At  a  gala  televised 
press conference that featured US President Bill Clinton 
and UK Prime Minister Tony Blair, the publicly funded 
Human Genome Project and the privately funded Celera 
Genomics  Corporation  announced  their  simultaneous 
completion of the draft sequence of the human genome. 
And nothing in biomedical research would ever be the 
same again.
Yes, Genome Biology was in on the ground floor of what 
has  been  one  of  the  greatest  transformations  in  the 
history  of  science.  What  molecular  biology  promised, 
genome biology has delivered: the maturation of biology 
into a truly molecular discipline. Because now, at last, we  © 2010 BioMed Central Ltd
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© 2010 BioMed Central Ltdhave  the  parts  list.  In  principle,  we  can  know  all  the 
molecules that a cell can make. Of course, the magnificent 
irony of this knowledge is that it does us very little good 
without  a  simultaneous  change  in  thinking  that  goes 
beyond the molecular and back to a time when whole 
pathways,  organelles,  cells  and  organs  and  organisms 
were  studied.  Thus,  genome  sequencing,  the  ultimate 
tool  of  reductionist  thinking  -  which  gave  birth  to 
metabolomics and transcriptomics and a host of other 
data  gathering  ‘omics’,  welcome  or  not  -  has  led, 
inevitably, to systems biology (whatever that is), and to a 
rebirth of the noble discipline of physiology. Like it or 
not, biology has become Big Science, and the Pandora’s 
Box that genomics has opened cannot be closed again.
I have been trying to offer my personal take on this sea 
change in an opinion column that has appeared in every 
issue since the first one. The editors have allowed me free 
rein to do this any way I wish: satire, imaginary dialogs, 
even short dramas. In turn, I’ve tried to be provocative, 
imaginative, and entertaining. Whether I’ve succeeded or 
not is not for me to say. But what I can say is that I have 
had, thanks to this publication, a front-row seat for the 
kind of change in a field that comes along only once or 
twice in a lifetime.
Genome  Biology  has  chronicled  this  metamorphosis 
with style and insight. The first of its kind, it remains the 
best of its kind in my opinion. Other journals will follow 
its ascent (or is it descent?) to exclusive online content 
with the inevitability of a sunrise. They may also imitate 
its  unique  blend  of  commentary,  review,  humor,  peer-
reviewed science, and series. But they can’t say that they 
saw  what  was  coming,  because  few  did.  I  think  it’s 
completely  appropriate  to  engage  in  a  few  self-
congratulations,  to  which  I  will  add  mine:  well  done, 
gang.
So where do we go from here? Biology is still changing, 
and a journal that aims to be at the cutting edge will have 
to  change  with  it.  My  own  guess  is  that  biological 
research  in  the  age  of  genomics  will  move  inexorably 
towards more human biology, and more direct relevance 
to human disease. This is partly a natural progression, but 
it is also driven by the increased demand that big science 
deliver on the promises made to convince the public to 
support  it.  Genomics  was  born  of  a  promise  that 
understanding  the  workings  of  the  cell  would  lead  to 
faster cures, and that promise hasn’t been kept. Funding 
agencies and government officials and patient advocacy 
groups are going to hold us to that promise, and their 
impatience  will  be  the  prime  driver  for  the  field.  To 
continue to be au courant, Genome Biology will need to 
increase its coverage not only of research related to the 
human genome, but also of disease-related research that 
makes  use  of  both  the  tools  and  the  discoveries  of 
genomics.
The  scientific  changes  have  been  amazing,  and  will 
continue to be so, but equally amazing, I think, are the 
changes  in  the  culture  of  science  that  genomics  has 
wrought. These are even harder to predict, but a good 
guess would be an increased rewarding of collaboration 
rather than an insistence that one’s reputation be built 
entirely by one’s own hands. Another might be an almost 
complete  blurring  of  the  lines  between  traditional 
disciplines,  such  that  academic  departments  are  out-
moded  and  allegiances  become  fluid.  Biology  will  also 
become  more  data-driven,  quantitative,  and  computa-
tional than ever before, which will mean a very different 
sort of scientist will probably become king in this new 
world.
Anyway, I intend to keep writing about it all, for as long 
as Genome Biology exists, or until they get sick of me. 
Sorry about that.
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